[2]
GOLDSTEIN JE, COGAN DG. APRAXIA OF LID OPENING. Archives of ophthalmology (Chicago, Ill. : 1960). 1965 Feb:73():155-9
[PubMed PMID: 14237780]
[4]
Knight B, Lopez MJ, Patel BC. Anatomy, Head and Neck: Eye Levator Palpebrae Superioris Muscles. StatPearls. 2023 Jan:():
[PubMed PMID: 30725606]
[5]
Mustafa MM, Akram H, Oliva-Domínguez M, Kaski D. Functional positional eye and eyelid movements. Journal of neurology. 2020 Nov:267(11):3425-3428. doi: 10.1007/s00415-020-10071-7. Epub 2020 Jul 15
[PubMed PMID: 32671528]
[6]
Phokaewvarangkul O, Bhidayasiri R. How to spot ocular abnormalities in progressive supranuclear palsy? A practical review. Translational neurodegeneration. 2019:8():20. doi: 10.1186/s40035-019-0160-1. Epub 2019 Jul 10
[PubMed PMID: 31333840]
[7]
Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics. International journal of molecular sciences. 2022 Feb 6:23(3):. doi: 10.3390/ijms23031851. Epub 2022 Feb 6
[PubMed PMID: 35163773]
[9]
Hamedani AG, Gold DR. Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease. Frontiers in neurology. 2017:8():329. doi: 10.3389/fneur.2017.00329. Epub 2017 Jul 18
[PubMed PMID: 28769865]
[10]
Bhattacharjee K, Misra DK, Deori N. Updates on upper eyelid blepharoplasty. Indian journal of ophthalmology. 2017 Jul:65(7):551-558. doi: 10.4103/ijo.IJO_540_17. Epub
[PubMed PMID: 28724810]
[11]
Digre KB, Brennan KC. Shedding light on photophobia. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2012 Mar:32(1):68-81. doi: 10.1097/WNO.0b013e3182474548. Epub
[PubMed PMID: 22330853]
[12]
Dorsett M, Liang SY. Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department. Emergency medicine clinics of North America. 2016 Nov:34(4):917-942. doi: 10.1016/j.emc.2016.06.013. Epub
[PubMed PMID: 27741995]
[14]
Jaishankar M, Tseten T, Anbalagan N, Mathew BB, Beeregowda KN. Toxicity, mechanism and health effects of some heavy metals. Interdisciplinary toxicology. 2014 Jun:7(2):60-72. doi: 10.2478/intox-2014-0009. Epub 2014 Nov 15
[PubMed PMID: 26109881]
[15]
Pula JH, Yuen CA. Eyes and stroke: the visual aspects of cerebrovascular disease. Stroke and vascular neurology. 2017 Dec:2(4):210-220. doi: 10.1136/svn-2017-000079. Epub 2017 Jul 6
[PubMed PMID: 29507782]
[16]
Bhagavati S. Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy. Frontiers in neurology. 2021:12():664664. doi: 10.3389/fneur.2021.664664. Epub 2021 Apr 14
[PubMed PMID: 33935958]
[17]
Jackson M, Marks L, May GHW, Wilson JB. The genetic basis of disease. Essays in biochemistry. 2018 Dec 3:62(5):643-723. doi: 10.1042/EBC20170053. Epub 2018 Dec 2
[PubMed PMID: 30509934]
[18]
Sun Y, Tsai PJ, Chu CL, Huang WC, Bee YS. Epidemiology of benign essential blepharospasm: A nationwide population-based retrospective study in Taiwan. PloS one. 2018:13(12):e0209558. doi: 10.1371/journal.pone.0209558. Epub 2018 Dec 26
[PubMed PMID: 30586395]
Level 2 (mid-level) evidence
[19]
Iyengar SS, Narasingan SN, Gandhi P, Jaipuriar N, Mahilmaran A, Patil S, Abhyankar MV, Revankar S. Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study. Journal of family medicine and primary care. 2020 Aug:9(8):4156-4164. doi: 10.4103/jfmpc.jfmpc_546_20. Epub 2020 Aug 25
[PubMed PMID: 33110825]
[20]
Weiss D, Wächter T, Breit S, Jacob SN, Pomper JK, Asmus F, Valls-Solé J, Plewnia C, Gasser T, Gharabaghi A, Krüger R. Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities. Journal of neurology, neurosurgery, and psychiatry. 2010 Sep:81(9):1002-7. doi: 10.1136/jnnp.2009.196691. Epub 2010 Jun 20
[PubMed PMID: 20562465]
[21]
Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. International journal of molecular sciences. 2022 May 25:23(11):. doi: 10.3390/ijms23115954. Epub 2022 May 25
[PubMed PMID: 35682631]
[22]
Yanagisawa N. Functions and dysfunctions of the basal ganglia in humans. Proceedings of the Japan Academy. Series B, Physical and biological sciences. 2018:94(7):275-304. doi: 10.2183/pjab.94.019. Epub
[PubMed PMID: 30078828]
[23]
Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinson's disease. 2022 May 11:8(1):56. doi: 10.1038/s41531-022-00321-y. Epub 2022 May 11
[PubMed PMID: 35546556]
[25]
Wallwork SB, Talbot K, Camfferman D, Moseley GL, Iannetti GD. The blink reflex magnitude is continuously adjusted according to both current and predicted stimulus position with respect to the face. Cortex; a journal devoted to the study of the nervous system and behavior. 2016 Aug:81():168-75. doi: 10.1016/j.cortex.2016.04.009. Epub 2016 Apr 22
[PubMed PMID: 27236372]
[26]
Asan AS, McIntosh JR, Carmel JB. Targeting Sensory and Motor Integration for Recovery of Movement After CNS Injury. Frontiers in neuroscience. 2021:15():791824. doi: 10.3389/fnins.2021.791824. Epub 2022 Jan 21
[PubMed PMID: 35126040]
[29]
Stoker TB, Greenland JC, Kouli A, Torsney KM, Kuan WL. Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis. Parkinson’s Disease: Pathogenesis and Clinical Aspects. 2018 Dec 21:():
[PubMed PMID: 30702842]
[30]
Juárez Olguín H, Calderón Guzmán D, Hernández García E, Barragán Mejía G. The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress. Oxidative medicine and cellular longevity. 2016:2016():9730467. doi: 10.1155/2016/9730467. Epub 2015 Dec 6
[PubMed PMID: 26770661]
[31]
Benghanem S, Mazeraud A, Azabou E, Chhor V, Shinotsuka CR, Claassen J, Rohaut B, Sharshar T. Brainstem dysfunction in critically ill patients. Critical care (London, England). 2020 Jan 6:24(1):5. doi: 10.1186/s13054-019-2718-9. Epub 2020 Jan 6
[PubMed PMID: 31907011]
[32]
Hoffmann M. The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective. ISRN neurology. 2013:2013():892459. doi: 10.1155/2013/892459. Epub 2013 Mar 14
[PubMed PMID: 23577266]
Level 3 (low-level) evidence
[33]
Lepeta K, Lourenco MV, Schweitzer BC, Martino Adami PV, Banerjee P, Catuara-Solarz S, de La Fuente Revenga M, Guillem AM, Haidar M, Ijomone OM, Nadorp B, Qi L, Perera ND, Refsgaard LK, Reid KM, Sabbar M, Sahoo A, Schaefer N, Sheean RK, Suska A, Verma R, Vicidomini C, Wright D, Zhang XD, Seidenbecher C. Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students. Journal of neurochemistry. 2016 Sep:138(6):785-805. doi: 10.1111/jnc.13713. Epub 2016 Sep 8
[PubMed PMID: 27333343]
Level 2 (mid-level) evidence
[34]
Rabiu TB. Revisiting the eye opening response of the Glasgow Coma Scale. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine. 2011 Jan:15(1):58-9. doi: 10.4103/0972-5229.78231. Epub
[PubMed PMID: 21633551]
[35]
Meer E, Grob S, Antonsen EL, Sawyer A. Ocular conditions and injuries, detection and management in spaceflight. NPJ microgravity. 2023 May 16:9(1):37. doi: 10.1038/s41526-023-00279-y. Epub 2023 May 16
[PubMed PMID: 37193709]
[36]
Krishnan S, Shetty K, Puthanveedu DK, Kesavapisharady K, Thulaseedharan JV, Sarma G, Kishore A. Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease-Frequency, Risk Factors and Response to Treatment. Movement disorders clinical practice. 2021 May:8(4):587-593. doi: 10.1002/mdc3.13206. Epub 2021 Apr 12
[PubMed PMID: 33981792]
[37]
Stoker TB, Greenland JC, Greenland JC, Barker RA. The Differential Diagnosis of Parkinson’s Disease. Parkinson’s Disease: Pathogenesis and Clinical Aspects. 2018 Dec 21:():
[PubMed PMID: 30702839]
[38]
Defazio G, Hallett M, Jinnah HA, Berardelli A. Development and validation of a clinical guideline for diagnosing blepharospasm. Neurology. 2013 Jul 16:81(3):236-40. doi: 10.1212/WNL.0b013e31829bfdf6. Epub 2013 Jun 14
[PubMed PMID: 23771487]
Level 1 (high-level) evidence
[39]
Li S, Nguyen IP, Urbanczyk K. Common infectious diseases of the central nervous system-clinical features and imaging characteristics. Quantitative imaging in medicine and surgery. 2020 Dec:10(12):2227-2259. doi: 10.21037/qims-20-886. Epub
[PubMed PMID: 33269224]
Level 2 (mid-level) evidence
[40]
Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, Hill MD, Patronas N, Latour L, Warach S. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet (London, England). 2007 Jan 27:369(9558):293-8
[PubMed PMID: 17258669]
[41]
Krack P, Marion MH. "Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients. Movement disorders : official journal of the Movement Disorder Society. 1994 Nov:9(6):610-5
[PubMed PMID: 7845400]
[42]
Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Ferrazzano G, Wagle-Shukla A, Malaty IA, Jankovic J, Bellows ST, Barbano RL, Vidailhet M, Roze E, Bonnet C, Mahajan A, LeDoux MS, Fung VSC, Chang FCF, Defazio G, Ercoli T, Factor S, Wojno T, Jinnah HA. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022:1():. pii: 10359. doi: 10.3389/dyst.2022.10359. Epub 2022 May 16
[PubMed PMID: 36248010]
Level 1 (high-level) evidence
[43]
Wilkes J. AAN Updates Guidelines on the Uses of Botulinum Neurotoxin. American family physician. 2017 Feb 1:95(3):198-199
[PubMed PMID: 28145664]
[44]
Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 May 10:86(19):1818-26. doi: 10.1212/WNL.0000000000002560. Epub 2016 Apr 18
[PubMed PMID: 27164716]
Level 1 (high-level) evidence
[45]
Kerty E, Eidal K. Apraxia of eyelid opening: clinical features and therapy. European journal of ophthalmology. 2006 Mar-Apr:16(2):204-8
[PubMed PMID: 16703535]
[46]
Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014 Apr 23-30:311(16):1670-83. doi: 10.1001/jama.2014.3654. Epub
[PubMed PMID: 24756517]
[47]
Hellman A, Torres-Russotto D. Botulinum toxin in the management of blepharospasm: current evidence and recent developments. Therapeutic advances in neurological disorders. 2015 Mar:8(2):82-91. doi: 10.1177/1756285614557475. Epub
[PubMed PMID: 25922620]
Level 3 (low-level) evidence
[48]
Azuma R, Aoki S, Aizawa T, Kuwabara M, Kiyosawa T. The vertical orbicularis oculi muscle turn-over procedure for the correction of paralytic ectropion of the lower eyelid. Archives of plastic surgery. 2018 Mar:45(2):135-139. doi: 10.5999/aps.2017.01235. Epub 2018 Mar 5
[PubMed PMID: 29506332]
[49]
Patel N, Jankovic J, Hallett M. Sensory aspects of movement disorders. The Lancet. Neurology. 2014 Jan:13(1):100-12. doi: 10.1016/S1474-4422(13)70213-8. Epub
[PubMed PMID: 24331796]
[50]
Ramos VF, Karp BI, Hallett M. Tricks in dystonia: ordering the complexity. Journal of neurology, neurosurgery, and psychiatry. 2014 Sep:85(9):987-93. doi: 10.1136/jnnp-2013-306971. Epub 2014 Jan 31
[PubMed PMID: 24487380]
[51]
Marsden CD. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? Journal of neurology, neurosurgery, and psychiatry. 1976 Dec:39(12):1204-9
[PubMed PMID: 1011031]
[52]
Marsden CD. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia). Advances in neurology. 1976:14():259-76
[PubMed PMID: 941774]
Level 3 (low-level) evidence
[53]
Zádori D, Veres G, Szalárdy L, Klivényi P, Vécsei L. Drug-induced movement disorders. Expert opinion on drug safety. 2015 Jun:14(6):877-90. doi: 10.1517/14740338.2015.1032244. Epub
[PubMed PMID: 25981904]
Level 3 (low-level) evidence
[54]
Defazio G, De Mari M, De Salvia R, Lamberti P, Giorelli M, Livrea P. "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report. Clinical neuropharmacology. 1999 Sep-Oct:22(5):292-4
[PubMed PMID: 10516881]
[55]
Umemura A, Toyoda T, Yamamoto K, Oka Y, Ishii F, Yamada K. Apraxia of eyelid opening after subthalamic deep brain stimulation may be caused by reduction of levodopa. Parkinsonism & related disorders. 2008 Dec:14(8):655-7. doi: 10.1016/j.parkreldis.2007.12.008. Epub 2008 Mar 3
[PubMed PMID: 18316231]
[56]
Vagefi MR, Lin CC, McCann JD, Anderson RL. Exacerbation of blepharospasm associated with craniocervical dystonia after placement of bilateral globus pallidus internus deep brain stimulator. Movement disorders : official journal of the Movement Disorder Society. 2008 Feb 15:23(3):454-6
[PubMed PMID: 18074391]
[57]
Defazio G, Matarin M, Peckham EL, Martino D, Valente EM, Singleton A, Crawley A, Aniello MS, Brancati F, Abbruzzese G, Girlanda P, Livrea P, Hallett M, Berardelli A. The TOR1A polymorphism rs1182 and the risk of spread in primary blepharospasm. Movement disorders : official journal of the Movement Disorder Society. 2009 Mar 15:24(4):613-6. doi: 10.1002/mds.22471. Epub
[PubMed PMID: 19202559]
[58]
Siokas V, Dardiotis E, Tsironi EE, Tsivgoulis G, Rikos D, Sokratous M, Koutsias S, Paterakis K, Deretzi G, Hadjigeorgiou GM. The Role of TOR1A Polymorphisms in Dystonia: A Systematic Review and Meta-Analysis. PloS one. 2017:12(1):e0169934. doi: 10.1371/journal.pone.0169934. Epub 2017 Jan 12
[PubMed PMID: 28081261]
Level 1 (high-level) evidence
[59]
Chen Y, Chen K, Burgunder JM, Song W, Huang R, Zhao B, Cao B, Chen X, Jiang Y, Shang HF. Association of rs1182 polymorphism of the DYT1 gene with primary dystonia in Chinese population. Journal of the neurological sciences. 2012 Dec 15:323(1-2):228-31. doi: 10.1016/j.jns.2012.09.025. Epub 2012 Oct 9
[PubMed PMID: 23058565]
[60]
Fuchs T, Saunders-Pullman R, Masuho I, Luciano MS, Raymond D, Factor S, Lang AE, Liang TW, Trosch RM, White S, Ainehsazan E, Hervé D, Sharma N, Ehrlich ME, Martemyanov KA, Bressman SB, Ozelius LJ. Mutations in GNAL cause primary torsion dystonia. Nature genetics. 2013 Jan:45(1):88-92. doi: 10.1038/ng.2496. Epub 2012 Dec 9
[PubMed PMID: 23222958]
[61]
Charlesworth G, Plagnol V, Holmström KM, Bras J, Sheerin UM, Preza E, Rubio-Agusti I, Ryten M, Schneider SA, Stamelou M, Trabzuni D, Abramov AY, Bhatia KP, Wood NW. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. American journal of human genetics. 2012 Dec 7:91(6):1041-50. doi: 10.1016/j.ajhg.2012.10.024. Epub 2012 Nov 29
[PubMed PMID: 23200863]
[62]
Hersheson J, Mencacci NE, Davis M, MacDonald N, Trabzuni D, Ryten M, Pittman A, Paudel R, Kara E, Fawcett K, Plagnol V, Bhatia KP, Medlar AJ, Stanescu HC, Hardy J, Kleta R, Wood NW, Houlden H. Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Annals of neurology. 2013 Apr:73(4):546-53. doi: 10.1002/ana.23832. Epub 2013 Feb 19
[PubMed PMID: 23424103]
[63]
Xiao J, Uitti RJ, Zhao Y, Vemula SR, Perlmutter JS, Wszolek ZK, Maraganore DM, Auburger G, Leube B, Lehnhoff K, LeDoux MS. Mutations in CIZ1 cause adult onset primary cervical dystonia. Annals of neurology. 2012 Apr:71(4):458-69. doi: 10.1002/ana.23547. Epub 2012 Mar 23
[PubMed PMID: 22447717]
[64]
Khooshnoodi MA, Factor SA, Jinnah HA. Secondary blepharospasm associated with structural lesions of the brain. Journal of the neurological sciences. 2013 Aug 15:331(1-2):98-101. doi: 10.1016/j.jns.2013.05.022. Epub 2013 Jun 6
[PubMed PMID: 23747003]
[65]
Hara K, Matsuda A, Kitsukawa Y, Tanaka K, Nishizawa M, Tagawa A. Botulinum toxin treatment for blepharospasm associated with myasthenia gravis. Movement disorders : official journal of the Movement Disorder Society. 2007 Jul 15:22(9):1363-4
[PubMed PMID: 17486596]
[66]
Kurlan R, Jankovic J, Rubin A, Patten B, Griggs R, Shoulson I. Coexistent Meige's syndrome and myasthenia gravis. A relationship between blinking and extraocular muscle fatigue? Archives of neurology. 1987 Oct:44(10):1057-60
[PubMed PMID: 3632379]
[67]
Finsterer J. Ptosis: causes, presentation, and management. Aesthetic plastic surgery. 2003 May-Jun:27(3):193-204
[PubMed PMID: 12925861]
[69]
Cornett EM, Novitch M, Kaye AD, Kata V, Kaye AM. Medication-Induced Tardive Dyskinesia: A Review and Update. Ochsner journal. 2017 Summer:17(2):162-174
[PubMed PMID: 28638290]
[70]
Jarrett A, Emery JM, Coats AC, Justice J Jr. Voluntary nystagmus. Annals of ophthalmology. 1977 Jul:9(7):853-9
[PubMed PMID: 900720]
[71]
Duarte GS, Rodrigues FB, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J. Botulinum toxin type A therapy for blepharospasm. The Cochrane database of systematic reviews. 2020 Nov 19:11(11):CD004900. doi: 10.1002/14651858.CD004900.pub3. Epub 2020 Nov 19
[PubMed PMID: 33211907]
Level 1 (high-level) evidence
[72]
Coughlin DG, Litvan I. Progressive supranuclear palsy: Advances in diagnosis and management. Parkinsonism & related disorders. 2020 Apr:73():105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25
[PubMed PMID: 32487421]
Level 3 (low-level) evidence
[73]
Rowe JB, Holland N, Rittman T. Progressive supranuclear palsy: diagnosis and management. Practical neurology. 2021 Oct:21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2
[PubMed PMID: 34215700]
[74]
Ramirez-Castaneda J, Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon : official journal of the International Society on Toxinology. 2014 Nov:90():344-8. doi: 10.1016/j.toxicon.2014.07.009. Epub 2014 Aug 15
[PubMed PMID: 25130293]
[75]
Jochim A, Meindl T, Huber C, Mantel T, Zwirner S, Castrop F, Haslinger B. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice. Journal of neurology. 2020 Jan:267(1):267-275. doi: 10.1007/s00415-019-09581-w. Epub 2019 Oct 19
[PubMed PMID: 31630241]
[76]
Diep D, Ko J, Lan J, Koprowicz KT, Ko G. Benefits, Safety, and Adjunct Modality Prevalences of Long-Term Botulinum Toxin Injections for Cervical Dystonia and Myofascial Neck Pain: A Retrospective Cohort Study. Journal of pain research. 2020:13():1297-1304. doi: 10.2147/JPR.S254032. Epub 2020 Jun 3
[PubMed PMID: 32581571]
Level 2 (mid-level) evidence
[77]
Lee D, Lee S. The influence of social withdrawal and depression on the self-esteem of female adolescents: The mediating effect of grit. PloS one. 2023:18(7):e0288530. doi: 10.1371/journal.pone.0288530. Epub 2023 Jul 12
[PubMed PMID: 37437061]
[78]
Miller DD, Hasan SA, Simmons NL, Stewart MW. Recurrent corneal erosion: a comprehensive review. Clinical ophthalmology (Auckland, N.Z.). 2019:13():325-335. doi: 10.2147/OPTH.S157430. Epub 2019 Feb 11
[PubMed PMID: 30809089]
[79]
Witmanowski H, Błochowiak K. The whole truth about botulinum toxin - a review. Postepy dermatologii i alergologii. 2020 Dec:37(6):853-861. doi: 10.5114/ada.2019.82795. Epub 2019 Feb 5
[PubMed PMID: 33603602]
[80]
An SH, Jin SW, Kwon YH, Ryu WY, Jeong WJ, Ahn HB. Effects of upper lid blepharoplasty on visual quality in patients with lash ptosis and dermatochalasis. International journal of ophthalmology. 2016:9(9):1320-4. doi: 10.18240/ijo.2016.09.15. Epub 2016 Sep 18
[PubMed PMID: 27672599]
Level 2 (mid-level) evidence
[81]
Akhtar A, Macfarlane RJ, Waseem M. Pre-operative assessment and post-operative care in elective shoulder surgery. The open orthopaedics journal. 2013:7():316-22. doi: 10.2174/1874325001307010316. Epub 2013 Sep 6
[PubMed PMID: 24093051]
[82]
Pollock A, Baer G, Campbell P, Choo PL, Forster A, Morris J, Pomeroy VM, Langhorne P. Physical rehabilitation approaches for the recovery of function and mobility following stroke. The Cochrane database of systematic reviews. 2014 Apr 22:2014(4):CD001920. doi: 10.1002/14651858.CD001920.pub3. Epub 2014 Apr 22
[PubMed PMID: 24756870]
Level 1 (high-level) evidence
[83]
Pomeroy V, Aglioti SM, Mark VW, McFarland D, Stinear C, Wolf SL, Corbetta M, Fitzpatrick SM. Neurological principles and rehabilitation of action disorders: rehabilitation interventions. Neurorehabilitation and neural repair. 2011 Jun:25(5 Suppl):33S-43S. doi: 10.1177/1545968311410942. Epub
[PubMed PMID: 21613536]
[84]
Heckmann JG, Vachalova I, Lang CJG, Pitz S. Neuro-Ophthalmology at the Bedside: A Clinical Guide. Journal of neurosciences in rural practice. 2018 Oct-Dec:9(4):561-573. doi: 10.4103/jnrp.jnrp_145_18. Epub
[PubMed PMID: 30271051]
[85]
Yap Y, Morris R, Adapa R. Movement disorder surgery Part I: historical background and principle of surgery. BJA education. 2021 Apr:21(4):133-139. doi: 10.1016/j.bjae.2020.11.008. Epub 2021 Jan 21
[PubMed PMID: 33777411]
[86]
Legg LA, Lewis SR, Schofield-Robinson OJ, Drummond A, Langhorne P. Occupational therapy for adults with problems in activities of daily living after stroke. The Cochrane database of systematic reviews. 2017 Jul 19:7(7):CD003585. doi: 10.1002/14651858.CD003585.pub3. Epub 2017 Jul 19
[PubMed PMID: 28721691]
Level 1 (high-level) evidence
[87]
Gittins J, Martin K, Sheldrick J, Reddy A, Thean L. Electrical stimulation as a therapeutic option to improve eyelid function in chronic facial nerve disorders. Investigative ophthalmology & visual science. 1999 Mar:40(3):547-54
[PubMed PMID: 10067956]
[88]
Klapper SR, Patrinely JR. Management of cosmetic eyelid surgery complications. Seminars in plastic surgery. 2007 Feb:21(1):80-93. doi: 10.1055/s-2007-967753. Epub
[PubMed PMID: 20567662]
[89]
Ketenci A, Zure M. Pharmacological and non-pharmacological treatment approaches to chronic lumbar back pain. Turkish journal of physical medicine and rehabilitation. 2021 Mar:67(1):1-10. doi: 10.5606/tftrd.2021.8216. Epub 2021 Mar 4
[PubMed PMID: 33948537]
[90]
Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman medical journal. 2011 May:26(3):155-9. doi: 10.5001/omj.2011.38. Epub
[PubMed PMID: 22043406]
[91]
Reblin M, Uchino BN. Social and emotional support and its implication for health. Current opinion in psychiatry. 2008 Mar:21(2):201-5. doi: 10.1097/YCO.0b013e3282f3ad89. Epub
[PubMed PMID: 18332671]
Level 3 (low-level) evidence
[92]
Orcutt T, Vitek J, Patriat R, Harel N, Matsumoto J. Apraxia of Eyelid Opening Improved by Pallidal Stimulation in Progressive Supranuclear Palsy. Movement disorders clinical practice. 2020 Aug:7(6):698-700. doi: 10.1002/mdc3.13001. Epub 2020 Jul 16
[PubMed PMID: 32775519]
[93]
Yoon WT,Chung EJ,Lee SH,Kim BJ,Lee WY, Clinical analysis of blepharospasm and apraxia of eyelid opening in patients with parkinsonism. Journal of clinical neurology (Seoul, Korea). 2005 Oct;
[PubMed PMID: 20396463]
[94]
Lee JH, Han HS, Lee JK. The Importance of Early Recognition, Timely Management, and the Role of Healthcare Providers in Multisystem Inflammatory Syndrome in Children. Journal of Korean medical science. 2021 Jan 11:36(2):e17. doi: 10.3346/jkms.2021.36.e17. Epub 2021 Jan 11
[PubMed PMID: 33429476]
[95]
Al-Asmi A, Nandhagopal R, Jacob PC, Gujjar A. Misdiagnosis of Myasthenia Gravis and Subsequent Clinical Implication: A case report and review of literature. Sultan Qaboos University medical journal. 2012 Feb:12(1):103-8
[PubMed PMID: 22375266]
Level 3 (low-level) evidence
[96]
Paterick TE, Patel N, Tajik AJ, Chandrasekaran K. Improving health outcomes through patient education and partnerships with patients. Proceedings (Baylor University. Medical Center). 2017 Jan:30(1):112-113
[PubMed PMID: 28152110]
[97]
Rosen MA, DiazGranados D, Dietz AS, Benishek LE, Thompson D, Pronovost PJ, Weaver SJ. Teamwork in healthcare: Key discoveries enabling safer, high-quality care. The American psychologist. 2018 May-Jun:73(4):433-450. doi: 10.1037/amp0000298. Epub
[PubMed PMID: 29792459]
Level 2 (mid-level) evidence
[98]
Kadam RA. Informed consent process: A step further towards making it meaningful! Perspectives in clinical research. 2017 Jul-Sep:8(3):107-112. doi: 10.4103/picr.PICR_147_16. Epub
[PubMed PMID: 28828304]
Level 3 (low-level) evidence
[99]
Sheehan J, Laver K, Bhopti A, Rahja M, Usherwood T, Clemson L, Lannin NA. Methods and Effectiveness of Communication Between Hospital Allied Health and Primary Care Practitioners: A Systematic Narrative Review. Journal of multidisciplinary healthcare. 2021:14():493-511. doi: 10.2147/JMDH.S295549. Epub 2021 Feb 22
[PubMed PMID: 33654406]
Level 1 (high-level) evidence
[100]
Brault I, Kilpatrick K, D'Amour D, Contandriopoulos D, Chouinard V, Dubois CA, Perroux M, Beaulieu MD. Role clarification processes for better integration of nurse practitioners into primary healthcare teams: a multiple-case study. Nursing research and practice. 2014:2014():170514. doi: 10.1155/2014/170514. Epub 2014 Dec 1
[PubMed PMID: 25692039]
Level 3 (low-level) evidence
[101]
Shaw L, Bazzell AF, Dains JE. Botulinum Toxin for Side-Effect Management and Prevention of Surgical Complications in Patients Treated for Head and Neck Cancers and Esophageal Cancer. Journal of the advanced practitioner in oncology. 2019 Jan-Feb:10(1):40-52
[PubMed PMID: 31308987]